Back to directory
About
Isomorphic Labs is an Alphabet-owned AI drug discovery company spun out of Google DeepMind in 2021 and led by Demis Hassabis. It builds a next-generation AI drug design engine building on AlphaFold 3 and has multi-billion-dollar research collaborations with Eli Lilly and Novartis. In March 2025 it raised $600M in its first external round, led by Thrive Capital with GV and Alphabet.